Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) — Capital Reinvestment Ratio
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥55.69 Million) in capital expenditures (CN¥5.26 Million). See Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Cheng Yi Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Zhejiang Cheng Yi Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 15 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see market cap of Zhejiang Cheng Yi Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥280.39 Million | CN¥45.40 Million | ▼ -44.4% |
| 2024 | 0.29x | CN¥205.72 Million | CN¥59.89 Million | ▼ -20.0% |
| 2023 | 0.36x | CN¥194.78 Million | CN¥70.85 Million | ▼ -76.1% |
| 2022 | 1.52x | CN¥165.94 Million | CN¥252.85 Million | ▲ +63.0% |
| 2021 | 0.93x | CN¥143.49 Million | CN¥134.11 Million | ▲ +15.7% |
| 2020 | 0.81x | CN¥177.81 Million | CN¥143.67 Million | ▼ -20.4% |
| 2019 | 1.02x | CN¥181.01 Million | CN¥183.81 Million | ▼ -49.8% |
| 2018 | 2.02x | CN¥134.30 Million | CN¥271.52 Million | ▲ +255.2% |
| 2017 | 0.57x | CN¥66.75 Million | CN¥37.99 Million | ▲ +150.2% |
| 2016 | 0.23x | CN¥95.08 Million | CN¥21.63 Million | ▲ +11.1% |
| 2015 | 0.20x | CN¥81.94 Million | CN¥16.79 Million | ▼ -31.1% |
| 2014 | 0.30x | CN¥84.11 Million | CN¥25.01 Million | ▼ -39.2% |
| 2013 | 0.49x | CN¥48.19 Million | CN¥23.57 Million | ▲ +2.9% |
| 2012 | 0.48x | CN¥37.96 Million | CN¥18.05 Million | ▼ -65.4% |
| 2011 | 1.37x | CN¥10.04 Million | CN¥13.78 Million | — |